SHOKAT; Kevan M.
Patent Applications and Registrations
Patent applications and USPTO patent grants for SHOKAT; Kevan M..The latest application filed is for "chemically controlled monoclonal antibody target engagement".
Company Profile
9.28.44
- SHOKAT; Kevan M. - San Francisco CA
- Shokat; Kevan M - San Francisco CA
Patent Activity
| Patent | Date |
|---|---|
| Chemically Controlled Monoclonal Antibody Target Engagement App 20220289866 - CRAIK; Charles S. ; et al. | 2022-09-15 |
| Compositions and methods for treating neurodegenerative diseases and cardiomyopathy Grant 11,427,588 - Hertz , et al. August 30, 2 | 2022-08-30 |
| Immunophilin-dependent Inhibitors And Uses Thereof App 20220193242 - Shokat; Kevan M. ; et al. | 2022-06-23 |
| Aurora Kinase Inhibitors App 20220054489 - Meyerowitz; Justin Gabriel ; et al. | 2022-02-24 |
| Compositions and methods for treating parasitic diseases Grant 11,208,411 - Rutaganira , et al. December 28, 2 | 2021-12-28 |
| Compositions and methods for treating cancer Grant 11,136,297 - Shokat , et al. October 5, 2 | 2021-10-05 |
| Aurora kinase inhibitors Grant 11,135,222 - Meyerowitz , et al. October 5, 2 | 2021-10-05 |
| Compositions And Methods For Treating Cancer App 20210230183 - Ostrem; Jonathan ; et al. | 2021-07-29 |
| Compositions and methods for treating cancer Grant 11,008,334 - Ostrem , et al. May 18, 2 | 2021-05-18 |
| Compositions And Methods For Treating Parasitic Diseases App 20200291030 - Rutaganira; Florentine ; et al. | 2020-09-17 |
| Compositions And Methods For Treating Neurodegenerative Diseases And Cardiomyopathy App 20200283442 - Hertz; Nicholas T. ; et al. | 2020-09-10 |
| Compositions And Methods For Treating Cancer App 20200255446 - Kind Code | 2020-08-13 |
| Compositions and methods for treating neurodegenerative diseases and cardiomyopathy Grant 10,723,737 - Hertz , et al. | 2020-07-28 |
| Compositions And Methods For Treating Cancer App 20200131135 - Shokat; Kevan M. ; et al. | 2020-04-30 |
| Use Of Translational Profiling To Identify Target Molecules For Therapeutic Treatment App 20190136321 - Ruggero; Davide ; et al. | 2019-05-09 |
| ErbB Inhibitors and Uses Thereof App 20190119284 - Novotny; Christopher ; et al. | 2019-04-25 |
| Compositions And Methods For Treating Cancer App 20190119295 - Ostrem; Jonathan ; et al. | 2019-04-25 |
| Compositions and methods for treating cancer Grant 10,023,588 - Ostrem , et al. July 17, 2 | 2018-07-17 |
| Compositions And Methods For Treating Neurodegenerative Diseases And Cardiomyopathy App 20180072731 - Hertz; Nicholas T. ; et al. | 2018-03-15 |
| Substituted pyrazolo[3,4-D]pyrimidines and uses thereof Grant 9,895,373 - Dar , et al. February 20, 2 | 2018-02-20 |
| MTOR modulators and uses thereof Grant 9,629,843 - Shokat , et al. April 25, 2 | 2017-04-25 |
| Compositions And Methods For Treating Cancer App 20160368930 - Ostrem; Jonathan ; et al. | 2016-12-22 |
| Substituted Pyrazolo[3,4-d]pyrimidines And Uses Thereof App 20160354377 - Dar; Arvin C. ; et al. | 2016-12-08 |
| Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents Grant 9,512,125 - Shokat , et al. December 6, 2 | 2016-12-06 |
| PI3 kinase antagonists Grant 9,493,467 - Knight , et al. November 15, 2 | 2016-11-15 |
| Aurora Kinase Inhibitors App 20160250211 - Meyerowitz; Justin Gabriel ; et al. | 2016-09-01 |
| Methods and compositions for modulating Ire1, SRC and ABL activity Grant 9,382,230 - Walter , et al. July 5, 2 | 2016-07-05 |
| Pyrazolo Pyrimidine Derivatives And Methods Of Use Thereof App 20160168151 - Tanaka; Masahiro ; et al. | 2016-06-16 |
| Methods and compositions for kinase inhibition Grant 9,353,116 - Garske , et al. May 31, 2 | 2016-05-31 |
| Substituted pyrazolo[3,4-D]pyrimidines and uses thereof Grant 9,321,772 - Dar , et al. April 26, 2 | 2016-04-26 |
| Compositions And Methods For Treating Neurodegenerative Diseases And Cardiomyopathy App 20160108044 - Hertz; Nicholas T. ; et al. | 2016-04-21 |
| Mtor Modulators And Uses Thereof App 20160000789 - Shokat; Kevan M. ; et al. | 2016-01-07 |
| Compositions And Methods For Treating Cancer App 20150087628 - Ostrem; Jonathan ; et al. | 2015-03-26 |
| Pyrazolo Pyrimidine Derivatives And Methods Of Use Thereof App 20150031881 - Tanaka; Masahiro ; et al. | 2015-01-29 |
| Methods And Compositions For Modulating Ire1, Src, And Abl Activity App 20150011575 - Walter; Peter ; et al. | 2015-01-08 |
| P13 Kinase Antagonists App 20140288096 - Knight; Zachary A. ; et al. | 2014-09-25 |
| Use Of Translational Profiling To Identify Target Molecules For Therapeutic Treatment App 20140288097 - Ruggero; Davide ; et al. | 2014-09-25 |
| Substituted Pyrazolo[3,4-d]pyrimidines And Uses Thereof App 20140243357 - Dar; Arvin C. ; et al. | 2014-08-28 |
| Methods and compositions for modulating IRE1, SRC, and ABL activity Grant 8,815,885 - Walter , et al. August 26, 2 | 2014-08-26 |
| Fused ring heteroaryl kinase inhibitors Grant 8,697,709 - Dar , et al. April 15, 2 | 2014-04-15 |
| Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents Grant 8,642,604 - Knight , et al. February 4, 2 | 2014-02-04 |
| Methods And Compositions For Kinase Inhibition App 20130137708 - Garske; Adam L. ; et al. | 2013-05-30 |
| Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof App 20120065154 - Tanaka; Masahiro ; et al. | 2012-03-15 |
| Methods and Compositions for Modulating IRE1, SRC, and ABL Activity App 20110319436 - Walter; Peter ; et al. | 2011-12-29 |
| Kinase Antagonists App 20110301144 - Knight; Zachary A. ; et al. | 2011-12-08 |
| Fused Ring Heteroaryl Kinase Inhibitors App 20110275651 - Dar; Arvin ; et al. | 2011-11-10 |
| MTOR Modulators and Uses Thereof App 20110224223 - Shokat; Kevan M. ; et al. | 2011-09-15 |
| Anti-Inflammatory Pyrazolopyrimndines App 20110144134 - Shokat; Kevan M. ; et al. | 2011-06-16 |
| Kinase Antagonists App 20100009963 - KNIGHT; ZACHARY A. ; et al. | 2010-01-14 |
| P13 Kinase Antagonists App 20090270426 - Knight; Zachary A. ; et al. | 2009-10-29 |
| Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists Grant 7,585,868 - Knight , et al. September 8, 2 | 2009-09-08 |
| Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof App 20090181988 - Tanaka; Masahiro ; et al. | 2009-07-16 |
| Anti-inflammatory Pyrazolopyrimidines App 20090124638 - Shokat; Kevan M. ; et al. | 2009-05-14 |
| Mechanism-Based Crosslinkers App 20080261821 - Maly; Dustin ; et al. | 2008-10-23 |
| 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof Grant 7,429,596 - Tanaka , et al. September 30, 2 | 2008-09-30 |
| PI3 kinase antagonists App 20080032960 - Knight; Zachary A. ; et al. | 2008-02-07 |
| Kinase antagonists App 20070293516 - Knight; Zachary A. ; et al. | 2007-12-20 |
| Chemo-enzymatic process for proteome-wide mapping of post-translational modification App 20060246531 - Shokat; Kevan M. ; et al. | 2006-11-02 |
| Proteome-wide mapping of post-translational modifications using endopeptidases App 20060210978 - Shokat; Kevan M. ; et al. | 2006-09-21 |
| Engineered protein kinases which can utilize modified nucleotide triphosphate substrates Grant 7,049,116 - Shokat May 23, 2 | 2006-05-23 |
| Pyrazolo pyrimidine derivatives and methods of use thereof App 20050085472 - Tanaka, Masahiro ; et al. | 2005-04-21 |
| Methods for identifying cellular responses attributable to signaling molecule inhibition and inhibitors thereof Grant 6,610,483 - Shokat , et al. August 26, 2 | 2003-08-26 |
| High affinity inhibitors for target validation and uses thereof App 20030073218 - Shokat, Kevan M. | 2003-04-17 |
| Engineered protein kinases which can utilize modified nucleotide triphosphate substrates Grant 6,521,417 - Shokat February 18, 2 | 2003-02-18 |
| Engineered protein kinases which can utilize modified nucleotide triphosphate substrates App 20020146797 - Shokat, Kevan M. | 2002-10-10 |
| Engineered protein kinases which can utilize modified nucleotide triphosphate substrates Grant 6,390,821 - Shokat May 21, 2 | 2002-05-21 |
| High affinity protein kinase inhibitors Grant 6,383,790 - Shokat May 7, 2 | 2002-05-07 |
| Engineered protein kinases which can utilize modified nucleotide triphosphate substrates App 20020016976 - Shokat, Kevan M. | 2002-02-07 |
Company Registrations
| NCAGE Code | 4JZ11 | SHOKAT KEVAN M |
| CAGE Code | 4JZ11 | SHOKAT, KEVAN M |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 